You Position: Home > Paper
Treatment of mucormycosis
( views:354, downloads:192 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1673-4173.2007.01.006
- Key Word:
- 毛霉菌病;治疗
Abstract： 毛霉病是一种致死性真菌感染,是由毛霉目中的致病真菌感染所致,常侵犯中枢神经系统、肺、胃肠道、皮肤、眼眶和鼻窦等部位.毛霉病易侵犯血管,引起血栓和周围组织坏死,一旦发生,常危及生命.目前毛霉病的治疗比较困难,治疗的关键在于早期诊断、尽可能去除潜在的易感因素、适当的外科清创和恰当的抗真菌治疗.外科清创能提高患者的痊愈率,抗真菌治疗包括多种抗真菌药的使用(单用或联用),另外,还可给予高压氧和细胞因子等辅助治疗.
- [1]R D, Adam,G, Hunter,J, DiTomasso,etc.Mucormycosis: emerging prominence of cutaneous infections.[J].1994,19(1).
- [2]Véronique Hofman,Laurent Castillo,Frédéric Bétis,etc.Usefulness of frozen section in rhinocerebral mucormycosis diagnosis and management[J].2003,35(3).
- [3]Anagnostopolous I,Schilling A,Thiel E,etc.Improved outcome of zygomycosis in patients with hematological diseases?[J].2004,45(7).
- [4]O.A. Kerr,C. Bong,C. Wallis,etc.Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum[J].2004,150(6).
- [5]Ibrahim AS,Avanessian V,Spellberg B,etc.Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.[J].2003,47(10).
- [6]Lisardo, García-Covarrubias,Diana M, Barratt,Robert, Bartlett,etc.[Treatment of mucormycosis with adjunctive hyperbaric oxygen: five cases treated at the same institution and review of the literature].[J].1900,56.
- [7]Mark Tedder,John A. Spratt,Mark P. Anstadt,etc.Pulmonary mucormycosis: Results of medical and surgical therapy[J].1994,57(4).
- [8]Fothergill AnnetteW,McCarthy DoraI,Graybill JohnR,etc.In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.[J].2002,46(5).
- [9]P. Voitl,C. Scheibenpflug,T. Weber,etc.Combined Antifungal Treatment of Visceral Mucormycosis with Caspofungin and Liposomal Amphotericin B[J].2002,21(8).
- [10]Gil Lamaignere C,Simitsopoulou M,Maloukou A,etc.Interferon- gamma and Granulocyte-Macrophage Colony-Stimulating Factor Augment the Activity of Polymorphonuclear Leukocytes against Medically Important Zygomycetes.[J].2005,191(7).
- [11]Espinel-Ingroff A.Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.[J].1998,36(10).
- [12]Robson J,Eisen DP.Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis.[J].2004,47(3).
- [13]D. Quinio,A. Karam,J.-P. Leroy,etc.Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient[J].2004,42(2).
- [14]Brad, Spellberg,Yue, Fu,John E, Edwards,etc.Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.[J].2005,49(2).
- [15]Oh D,Notrica D.Primary cutaneous mucormycosis in infants and neonates: case report and review of the literature.[J].2002,37(11).
- [16]Edwards J Jr,Ibrahim A,Spellberg B.Novel perspectives on mucormycosis: pathophysiology, presentation, and management.[J].2005,18(3).
- [17]Jacobs P,Esterhuizen K,Wood L,etc.Eradication of invasive mucormycosis--effectiveness of the Echinocandin FK463.[J].2003,8(2).
- [18]Giannopoulou M,Toskas A,Petrikkos G,etc.Mucormycosis: ten-year experience at a tertiary-care center in Greece.[J].2003,22(12).
- [19]Walsh TJ,Abzug MJ.Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children.[J].2004,23(8).